【4/18更新】CiNii ArticlesのCiNii Researchへの統合について

Sonazoid造影超音波検査における門脈内Sonazoid停滞時間に関する検討

書誌事項

タイトル別名
  • Time intensity curves of Sonazoid in portal vein in the patients with chronic liver disease and in healthy volunteers

この論文をさがす

抄録

Sonazoid, an ultrasonography contrast agent which consists of perflubutane microbubbles with shells, is stable in blood vessels and remains for a long time. We investigated time intensity curves of Sonazoid in portal vein in the patients with chronic liver disease and healthy volunteers. Among 25 patients with chronic liver disease, Sonazoid remained at the rates of 54.8±15.2%, 32.5±13.3%, 25.2±12.2%, 8.8±7.1% in the portal vein, 10, 20, 30, and 60 minutes after injection, respectively. In healthy volunteers, Sonazoid remained at the rates of 60.1±12.9%, 41.4±11.4%, 32.0±10.3%, 7.8±4.5% in the portal vein, 10, 20, 30, and 60 minutes after injection, respectively. It is recommended that Kupffer images of Sonazoid-enhanced contrast ultrasonography is evaluated 60 minutes after injection of Sonazoid to avoid an influence of sonazoid remaining in the vessels.<br>

収録刊行物

  • 肝臓

    肝臓 50 (10), 593-594, 2009

    一般社団法人 日本肝臓学会

被引用文献 (3)*注記

もっと見る

参考文献 (7)*注記

もっと見る

関連論文

もっと見る

関連研究データ

もっと見る

関連図書・雑誌

もっと見る

関連博士論文

もっと見る

関連プロジェクト

もっと見る

関連その他成果物

もっと見る

詳細情報

問題の指摘

ページトップへ